Returning to Boston for the 4th year, the NeoAg Summit is the only industry-focused meeting dedicated solely to the full end-to-end development and commercialization of neoantigen-based cancer immunotherapies.

Bringing together this exclusive community of over 300+ industry leaders from pharma, biotech, academia, regulatory bodies, solution and service providers.